Fresenius Medical Care Ag ADR (FMS) Stock Price, Quote & News

Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract...

Industry: Medical Care Facilities

Sector: Healthcare

Phone: 49 6172 609 0

Website: www.freseniusmedicalcare.com

Address:

Else-Kröner-Strasse 1, Bad Homburg, Germany

ZacksResearch Jul. 10 at 6:17 PM

$FMS is on a growth tear with a 21.7% YTD rise — what's driving this momentum? 🚀 💼 Strategic acquisitions & partnerships are fueling expansion. 🌍 Strong global presence with market entries in Israel & India. 📈 Earnings beat estimates 4 quarters in a row, averaging a 6.6% surprise. ⚠️ However, a tough regulatory environment remains a concern. Discover the full growth strategy here 👉 https://www.zacks.com/stock/news/2571613/reasons-to-add-fresenius-medical-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2571613-body-1218&ADID=SYND_STOCKTWITS_TWEET_2_2571613_BODY_1218

0 · Reply

ZacksResearch Jul. 10 at 4:11 PM

$FMS gaining steam — but is it worth the risk? Acquisitions and partnerships are driving momentum, but a tough regulatory backdrop clouds the outlook. Opportunity or trap? Full breakdown here 👉 https://www.zacks.com/stock/news/2571613/reasons-to-add-fresenius-medical-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2571613-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2571613_TEASER

0 · Reply

Thestocktraderhubzee Jul. 7 at 8:59 AM

WATCHLIST JUL 07 2025. $FMS Fresenius Medical Care Partners With CCINSHAE To Extend HighVolumeHDF Access In Mexico Through Pilot Program For Uninsured Patients $PRZO ParaZero Receives Follow-On Order For SafeAir Drone Safety Systems From Australian Drone Technology Distributor $JNJ Johnson & Johnson Submits Application To The European Medicines Agency Seeking Indication Extension Of AKEEGA For The Treatment Of Adult Patients With Metastatic Hormone-Sensitive Prostate Cancer And HRR Gene Alterations $AMBP Citigroup Maintains Buy on Ardagh Metal Packaging, Raises Price Target to $5 $AGRO Adecoagro And Tether Sign MoU To Explore Strategic Collaboration Focused On Bitcoin Mining

0 · Reply

Rage_Against_The_Machine Jul. 3 at 12:03 PM

$FMS expands HighVolumeHDF access in Mexico with 240 new patients, while FDA-cleared 5008X system eyes US rollout. The CONVINCE trial's 23% mortality reduction adds clinical heft. At 0.58x book value, the market's still pricing this like a dialysis machine rather than a growth story. https://www.prnewswire.com/news-releases/fresenius-medical-care-collaborates-with-coordination-of-national-institutes-of-health-and-specialty-hospital-to-extend-access-to-innovative-dialysis-therapy-in-mexico-302497158.html

0 · Reply

RyGuy_79 Jul. 1 at 6:24 PM

$CRMD $FMS Pretty sure stopping death would fall under the “renal care innovation” category. Correct me if I’m wrong. https://www.zacks.com/stock/news/2543827/fms-stock-likely-to-gain-on-new-optimization-plan-fme-reignite

0 · Reply

SparkyReturns Jun. 24 at 3:33 PM

$TAK Something to look at. Small cap investing idea: ICU recently beat down from a capital raise a few days ago, which was just reported will make them Nasdaq compliant. Waiting on confirmation. ICU has a unique SCD device which treats Acute Kidney Infection and has also been approved for compassionate and emergency use for Sepsis. FDA loves it so much has granted multiple breakthrough device designations, and has even awarded grants. Also Dept of Defense money to study use in burn or trauma cases. The device can calm the cytokine storm which can happen in a variety of conditions from AKI to sepsis to heart attacks to burn cases, Covid, etc. TAM in the tens of Billions. Current market cap approx. 8M. Read that again. Let that sink in. Reversal incoming. Cheers! $SYK $DVA $FMS

0 · Reply

ZacksResearch Jun. 24 at 1:04 PM

$FMS unveils “FME Reignite” strategy — is this the game-changer for renal care? 🌟 🚀 Targeting €1.05B in sustainable cost savings by 2027 with FME25+ 🩺 Launching 5008X CAREsystem in the U.S., promising improved clinical outcomes 💶 €1B share buyback & 30-40% dividend payout to boost investor confidence Discover the full strategy breakdown here 👉 https://www.zacks.com/commentary/2543827/fms-stock-likely-to-gain-on-new-optimization-plan-fme-reignite?cid=sm-stocktwits-2-2543827-body&ADID=SYND_STOCKTWITS_TWEET_2_2543827_BODY

0 · Reply

ZacksResearch Jun. 24 at 11:46 AM

$FMS launching bold turnaround plan — is this the catalyst bulls needed? New “FME Reignite” initiative aims for €1B in cost savings, tech improvements, and juiced shareholder returns. Full breakdown here 👉 https://www.zacks.com/stock/news/2543827/fms-stock-likely-to-gain-on-new-optimization-plan-fme-reignite?cid=sm-stocktwits-2-2543827-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2543827_TEASER

0 · Reply

Estimize Jun. 23 at 9:03 PM

Wall St is expecting 0.49 EPS for $FMS Q2 [Reporting 08/05 BMO] http://www.estimize.com/intro/fms?chart=historical&metric_name=eps&utm_cont

0 · Reply

IntensiveCareUnit Jun. 23 at 6:26 PM

$ICU I just think we're sleeping on buyout instead of commercial ramp up if IA goes well in august. Fresenius $FMS and DaVita $DVA make so much money every quarter, why would they not want to control a product that directly impacts their main product of dialysis? Fresenius already knows about it, they manufacture the product. Why not bring it all in house? It'd be chump change for them.

1 · Reply

Fresenius Medical Care Collaborates with Coordination of National Institutes of Health and Specialty Hospital to Extend Access to Innovative Dialysis Therapy in Mexico

Jun 17, 2025, 1:21 PM EDT - 4 weeks ago

Fresenius Medical Care Launches Value-Based Care Segment, Eyes Growth Through Innovation, Efficiency

Jun 17, 2025, 8:56 AM EDT - 4 weeks ago

Fresenius Medical Care CEO Says Company Could Benefit From Obesity Drugs

Jun 17, 2025, 7:00 AM EDT - 4 weeks ago

Fresenius Medical Care Launches its Strategy FME Reignite with increased Profitability Aspirations, and a New Capital Allocation Framework to further enhance Value Creation

Jun 17, 2025, 4:08 AM EDT - 4 weeks ago

Fresenius Medical Care announces 1 bln euros share buyback programme

Jun 16, 2025, 3:06 PM EDT - 4 weeks ago

5 Stocks To Ride The German Market Rally

BNTX SAP

Jun 4, 2025, 8:00 AM EDT - 5 weeks ago

Fresenius Medical Care Begins Broader U.S. Commercialization of 5008X™ CAREsystem, Achieves Key Milestones in Efforts to Introduce High-Volume Hemodiafiltration Dialysis Therapy to Individuals with Kidney Disease in the U.S.

May 30, 2025, 8:00 AM EDT - 6 weeks ago

Fresenius Medical Care presents its new research and innovation for kidney care at European Renal Association Congress 2025

May 22, 2025, 11:45 AM EDT - 7 weeks ago

Fresenius Medical Care Annual General Meeting: Strong Performance Against Its Strategic Plan Results in Highest Dividend per Share in Its History

May 8, 2025, 3:08 AM EDT - 2 months ago

Fresenius Medical Care AG (FMS) Q1 2025 Earnings Conference Call Transcript

May 6, 2025, 7:00 AM EDT - 2 months ago

Fresenius Medical Care starts 2025 with strong organic revenue and income growth

May 6, 2025, 1:04 AM EDT - 2 months ago

Fresenius Medical Care tops market expectations in 1st quarter

Apr 9, 2025, 6:32 PM EDT - 3 months ago

BMO's Siegerman talks the impact of tariffs on pharmaceutical stocks

ABBV AMGN AZN BMY GSK JNJ LLY

Mar 13, 2025, 8:00 AM EDT - 4 months ago

Fresenius Medical Care publishes its joint Annual Report and Sustainability Statement for 2024: Building the Momentum

Mar 4, 2025, 3:57 AM EST - 4 months ago

Fresenius Medical Care's stock falls on Fresenius' stake sale

Feb 25, 2025, 2:59 PM EST - 5 months ago

Fresenius Medical Care AG (FMS) Q4 2024 Earnings Conference Call Transcript

Feb 25, 2025, 7:00 AM EST - 5 months ago

Fresenius Medical Care delivers 18% earnings growth in 2024 and continues the acceleration momentum into 2025

Feb 25, 2025, 1:14 AM EST - 5 months ago

Fresenius Medical Care slightly beats market estimates in fourth quarter

Feb 24, 2025, 8:00 AM EST - 5 months ago

Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics

DGX

Jan 31, 2025, 6:20 AM EST - 5 months ago

Fresenius Medical Care: A 'Buy' Going Into 2025

Dec 23, 2024, 9:00 AM EST - 7 months ago

Fresenius Medical Care Listed in The Dow Jones Sustainability World Index and for the 15th Time in The Dow Jones Sustainability Europe Index

Dec 20, 2024, 11:23 AM EST - 7 months ago

Fresenius Medical Care returns to Dax 40 Index

Nov 5, 2024, 8:33 PM EST - 9 months ago

Hard work paying off despite challenges from U.S. weather-related events: Fresenius Medical Care CEO

Nov 5, 2024, 2:34 PM EST - 9 months ago

Fresenius Medical Care AG (FMS) Q3 2024 Earnings Call Transcript

Nov 5, 2024, 7:00 AM EST - 9 months ago

Fresenius Medical Care reports strong operating income margin growth in the third quarter of 2024

Oct 21, 2024, 11:04 AM EDT - 9 months ago

Fresenius Medical Care Showcases Research and Innovations in Kidney Care at American Society of Nephrology (ASN) Kidney Week 2024

Oct 4, 2024, 4:04 PM EDT - 10 months ago

Fresenius Medical Care: Let's Look At The Upside

Sep 4, 2024, 8:00 AM EDT - 11 months ago

Fresenius Medical Care Grows Number of U.S. Patients Using Company's Home Hemodialysis Machines, Launches NxStage® Versi®HD with GuideMe Software

Jul 30, 2024, 9:30 PM EDT - 1 year ago

Fresenius Medical Care CEO says strategy is working as company delivers on transformation efforts

Jul 30, 2024, 12:39 PM EDT - 1 year ago

Fresenius Medical Care AG (FMS) Q2 2024 Earnings Call Transcript

Jul 30, 2024, 7:00 AM EDT - 1 year ago

Fresenius Medical Care delivers continued operating income improvements in the second quarter of 2024

Jul 13, 2024, 9:16 AM EDT - 1 year ago

US FTC probing DaVita, Fresenius Medical, Politico reports

DVA

Jun 25, 2024, 6:15 AM EDT - 1 year ago

Fresenius Medical Care: Significant Upside Remains

Jun 12, 2024, 8:00 AM EDT - 1 year ago

Fresenius Medical Care takes next important step towards goal to reduce CO2 emissions in its operations

May 23, 2024, 12:33 PM EDT - 1 year ago

Moody's and S&P change Fresenius Medical Care's rating outlook to stable

May 21, 2024, 10:00 AM EDT - 1 year ago

Fresenius Medical Care showcases leadership and innovation in kidney care disease at 61st European Renal Association (ERA) Congress 2024

May 16, 2024, 9:55 AM EDT - 1 year ago

Fresenius Medical Care Annual General Meeting: Company makes significant progress in its Transformation Efforts and confirms its ambitious 2024 Growth Targets

May 11, 2024, 6:42 AM EDT - 1 year ago

Fresenius Medical sees up to 2% US dialysis growth by year-end

May 7, 2024, 2:53 PM EDT - 1 year ago

Fresenius Medical Care AG (FMS) Q1 2024 Earnings Call Transcript

May 7, 2024, 10:30 AM EDT - 1 year ago

We have positive momentum in operating performance: Fresenius Medical Care CEO

May 7, 2024, 7:00 AM EDT - 1 year ago

Fresenius Medical Care starts the year with strong earnings growth

May 7, 2024, 4:08 AM EDT - 1 year ago

Fresenius Medical beats earnings expectations, keeps outlook; shares sink

Mar 22, 2024, 8:00 AM EDT - 1 year ago

Fresenius Medical Care publishes 2023 joint Annual Report and Sustainability Report: Shaping the Future of Kidney Care

Mar 19, 2024, 8:00 AM EDT - 1 year ago

Fresenius Medical Care launches "Augmented Reality" for training on Kidney Replacement Therapy device

Mar 13, 2024, 10:00 AM EDT - 1 year ago

Fresenius Medical Care appoints Jörg Häring as new Management Board member responsible for Legal, Compliance and Human Resources

Mar 5, 2024, 10:10 AM EST - 1 year ago

Fresenius Medical Care Achieves Next Milestone in Portfolio Optimization Program, Announcing Sale of Dialysis Clinics in Brazil, Colombia, Chile, Ecuador

Feb 20, 2024, 12:03 PM EST - 1 year ago

Fresenius Medical Care AG (FMS) Q4 2023 Earnings Call Transcript

Feb 20, 2024, 7:30 AM EST - 1 year ago

Fresenius Medical Care delivers on commitments in a year of fundamental transformation

Feb 8, 2024, 8:54 AM EST - 1 year ago

Fresenius Medical Care Brings Industry-Leading Dialysis Therapy to Kidney Disease Patients in the U.S., demonstrating Global Leadership in Medical Device and Membrane Engineering Technologies

Feb 5, 2024, 8:57 AM EST - 1 year ago

Fresenius Medical Care AG nominates Six Employee Representatives to the Supervisory Board

ZacksResearch Jul. 10 at 6:17 PM

0 · Reply

ZacksResearch Jul. 10 at 4:11 PM

0 · Reply

Thestocktraderhubzee Jul. 7 at 8:59 AM

0 · Reply

Rage_Against_The_Machine Jul. 3 at 12:03 PM

0 · Reply

RyGuy_79 Jul. 1 at 6:24 PM

0 · Reply

SparkyReturns Jun. 24 at 3:33 PM

0 · Reply

ZacksResearch Jun. 24 at 1:04 PM

0 · Reply

ZacksResearch Jun. 24 at 11:46 AM

0 · Reply

Estimize Jun. 23 at 9:03 PM

Wall St is expecting 0.49 EPS for $FMS Q2 [Reporting 08/05 BMO] http://www.estimize.com/intro/fms?chart=historical&metric_name=eps&utm_cont

0 · Reply

IntensiveCareUnit Jun. 23 at 6:26 PM

1 · Reply

FractionalShareWhale Jun. 18 at 2:45 PM

$FMS 🔥🔥🔥

0 · Reply

LewisDaKat Jun. 18 at 12:55 AM

News Article Fresenius Medical Care Launches its Strategy FME Reignite with increased Profitability Aspirations, and a New Capital Allocation Framework to further enhance Value Creation https://marketwirenews.com/news-releases/fresenius-medical-care-launches-its-strategy-fme-rei-5173163048165934.html $FMS

0 · Reply

wolverine Jun. 17 at 9:11 AM

$CRMD $FMS capital markets day presentation: https://freseniusmedicalcare.com/content/dam/fresenius-medical-care/global/en/03_investors/pdf/events/cmd/2025/FME_CMD_2025_Main_Presentation.pdf

3 · Reply

GJ_Rockabilt Jun. 11 at 2:25 PM

$FMS My son, in early twenties, needs a Kidney. He is "O Positive" Blood Type. Please, let me know if you are interested in donating one. Thanks.

0 · Reply

wolverine Jun. 9 at 6:04 PM

$CRMD how do we think a $FMS & $CRMD initial order will be announced? Do they both announce? Does only Cormedix? Does $FMS announce at the capital markets day next Tuesday 6/17?

2 · Reply

ZacksResearch Jun. 4 at 5:18 PM

$FMS up 25.1% YTD — what’s fueling this growth? 🚀 This Zacks Rank #2 (Buy) stock is thriving with strategic acquisitions and partnerships, expecting a 9.6% bottom-line improvement in earnings over the next five years. The company has also beaten earnings estimates in the last four quarters with an average surprise of 6.6%. Discover the growth drivers for Fresenius Medical Care 👉"https://www.zacks.com/commentary/2484770/reasons-to-add-fresenius-medical-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2484770-body&ADID=SYND_STOCKTWITS_TWEET_2_2484770_BODY

0 · Reply

ZacksResearch Jun. 4 at 4:06 PM

$FMS gaining ground — but is it worth the risk? The stock’s momentum is being fueled by acquisitions and partnerships, but the regulatory backdrop isn’t exactly smooth sailing. Full bull/bear setup here 👉 https://www.zacks.com/stock/news/2484770/reasons-to-add-fresenius-medical-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2484770-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2484770_TEASER

0 · Reply

Quantumup Jun. 4 at 1:21 PM

Lucid Capital🏁 $UNCY Buy-$12 and said "We are initiating coverage of Unicycive with a Buy rating and a $12/share 12-month Price Target" - "We estimate that OLC could capture >$1.3B in peak sales in the US within two years after launch in 2025" $TAK $SNY $ARDX AKBA $FMS Lucid Capital additionally said in its initiation report:

1 · Reply

GJ_Rockabilt Jun. 3 at 4:06 PM

$FMS Fresenius Partner Humacyte, gave tremendous News, today. https://www.globenewswire.com/news-release/2025/06/02/3091791/0/en/Humacyte-Clinical-Results-in-High-Risk-Dialysis-Patients-from-V007-Pivotal-Phase-3.html

0 · Reply

wolverine May. 29 at 2:53 PM

$CRMD what are the next events? Jeffries 6/5? I don’t think much will be said here. $FMS capital markets day 6/15? Do we hope for a run up into the Fresinius event?

1 · Reply

tobyford84 May. 14 at 8:34 PM

$ICU it means we no longer need $FMS to make our stuff, nice move towards independence, shows confidence

2 · Reply

GJ_Rockabilt May. 14 at 3:11 PM

$FMS Partner Humacyte's HUMA and HUMAW are Squeezin'. Dont miss jt..I Own HUMAW. Go, Fresenius!

0 · Reply

Market Cap	15.93B
Revenue (ttm)	20.92B
Net Income (ttm)	582.08M
EPS (ttm)	N/A
PE Ratio	15.45
Forward PE	12.21
Profit Margin	2.78%
Debt to Equity Ratio	0.44

Volume	189,000
Avg Vol	455,436
Day's Range	N/A - N/A
Shares Out	586.83M
Stochastic %K	7%
Beta	0.87
Analysts	Sell
Price Target	$29.74